CAMBRIDGE COGNITION HOLDINGS PLC Logo

CAMBRIDGE COGNITION HOLDINGS PLC

Digital brain health assessment platform for CNS clinical trials and research.

COG | IL

Overview

Corporate Details

ISIN(s):
GB00B8DV9647 (+2 more)
LEI:
213800SZKDIN122EPA96
Country:
United Kingdom
Address:
TUNBRIDGE COURT, TUNBRIDGE LANE, BOTTISHAM, CB25 9TU CAMBRIDGE
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cambridge Cognition Holdings PLC is a neuroscience technology company specializing in digital solutions for assessing brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, designed to accelerate drug development and enhance research. Its portfolio of technologies includes scientifically validated digital cognitive assessments (such as its flagship CANTAB® product), voice analysis, electronic questionnaires, and a comprehensive platform for decentralized clinical trials. With over 30 years of scientific validation, its highly sensitive tools enable precise measurement of cognitive changes in-clinic or at home. The company serves leading pharmaceutical organizations, academic research institutions, and healthcare professionals globally, with expertise across numerous therapeutic areas including Alzheimer's disease, depression, and schizophrenia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-05 08:35
Regulatory News Service
Change of Auditor
English 12.6 KB
2025-11-05 08:20
Board/Management Information
Board Updates
English 19.6 KB
2025-10-01 08:00
Share Issue/Capital Change
Block Listing Return
English 18.0 KB
2025-09-29 08:00
Declaration of Voting Results & Voting Rights Announcements
Exercise of Options and Total Voting Rights
English 13.9 KB
2025-09-26 10:59
Major Shareholding Notification
Holding(s) in Company
English 23.9 KB
2025-09-08 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-09-05 13:04
Major Shareholding Notification
Holding(s) in Company
English 52.9 KB
2025-09-02 18:21
Major Shareholding Notification
Holding(s) in Company
English 54.4 KB
2025-08-28 08:01
Board/Management Information
Changes to Board and Management
English 29.4 KB
2025-08-19 11:10
Regulatory News Service
Monument Therapeutics Partnership with FNIH
English 30.9 KB
2025-08-12 08:00
Earnings Release
Launch of Speaker Identification Solution
English 26.7 KB
2025-07-31 08:00
Earnings Release
Trading update for period ended 30 June 2025
English 22.4 KB
2025-06-27 13:27
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 31.6 KB
2025-06-04 08:00
Report Publication Announcement
Notice of AGM
English 14.4 KB
2025-05-06 18:59
Major Shareholding Notification
Holding(s) in Company
English 24.2 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE COGNITION HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE COGNITION HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE COGNITION HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland
RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland
RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland
RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom
SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom
SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom
SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland
SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden
SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom
SBTX
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden
TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.